NUDT15-mediated ACV and GCV metabolism (and pharmacogenetic variants in this gene) may be relevant beyond the transplant setting because these drugs are widely used for the prevention and treatment of a range of herpes virus and CMV infections in other immunocompromised patients, such as those with AIDS and also cancer patients undergoing chemotherapy56. The gene discussed is NUDT15; the disease is cytomegalovirus infection.